The American Journal of Medicine
Volume 123, Issue 4, Supplement , Pages S1-S3 , April 2010

Introduction

  • John G. Bartlett, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to John G. Bartlett, MD, 1830 East Monument Street, Room 447, Baltimore, MD 21205

References 

  1. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757–762
  2. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47:735–743
  3. Sabuncu E, David J, Bernède-Bauduin C, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009;6:e1000084
  4. Nolte FS. Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia. Clin Infect Dis. 2008;47(suppl 3):S123–S126
  5. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America and the American Thoracic Society Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–S72
  6. Bratzler DW, Ma A, Nsa W. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Clin Infect Dis. 2008;47(suppl 3):S193–S201
  7. Wachter RM, Flanders SA, Fee C, Pronovost PJ. Public reporting of antibiotic timing in patient with pneumonia: lessons from a flawed performance measure. Ann Intern Med. 2008;149:29–32
  8. Bartlett JG. Diagnostic studies for microbiology in community-acquired pneumonia. Clin Infect Dis. 2010;(in press)
  9. Cooper RJ, Hoffman JR, Bartlett JG, et al. Centers for Disease Control and Prevention Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Emerg Med. 2001;37:711–719
  10. Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet. 2008;371:908–914
  11. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2008;(2):CD000243
  12. Hessler JL, Piccirillo JF, Fang D, et al. Clinical outcomes of chronic rhinosinusitis in response to medical therapy: results of a prospective study. Am J Rhinol. 2007;21:10–18
  13. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A. Clostridium difficile–associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–472
  14. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–2441
  15. Kallen AJ, Thompson A, Ristaino P, et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol. 2009;30:264–272
  16. Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173:1037–1942
  17. Kallen AJ, Thompson A, Ristaino P. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol. 2009;30:264–272
  18. Lim WS, Baudouin SV, George RC, et al. Pneumonia Guidelines Committee of the BTS Standards of Care Committee BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–iii55

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9343(10)00096-3

doi: 10.1016/j.amjmed.2010.02.001

The American Journal of Medicine
Volume 123, Issue 4, Supplement , Pages S1-S3 , April 2010

Article Tools